NAFLD disrupts glucose metabolism through several key mechanisms: Hepatic insulin resistance develops primarily through lipid accumulation-induced impairment of IRS phosphorylation, while concurrent mitochondrial dysfunction activates the ROS-JNK pathway, further disrupting insulin signaling. Here, INS is linked to Insulin resistance.